Three Motley Fool contributors believe they have found some great dividend stocks that fit the bill. Here's why they think ...

Dividend growth stocks have long been reliable engines of wealth creation. Historically, companies with 10-year annualized ...

Abbott Laboratories is a dividend stock you ... stronger after losing patent exclusivity for its blockbuster drug Humira. Johnson & Johnson is a seasoned dividend payer for all seasons.

Humira is a treatment for moderate to severe rheumatoid arthritis, the first of six disease indications it has received en route to becoming Abbott's most successful product ever. Abbott acquired ...

Abbott Laboratories has been paying a dividend ... a matter of time before key patents for its autoimmune disease drug Humira would expire. The company was heavily dependent on Humira's sales.

but with adalimumab biosimilars now on the market the focus has shifted to the tax avoidance issue. After spinning off from Abbott in 2013, AbbVie's corporate tax paid came in at an average of ...

Abbott Laboratories is a dividend stock you ... stronger after losing patent exclusivity for its blockbuster drug Humira. Johnson & Johnson is a seasoned dividend payer for all seasons.

Abbott (3-0) yielded four hits and three walks over five shutout innings Sunday, striking out five and earning a win over the Guardians. Abbott kept Cleveland scoreless for five frames but needed ...

AUSTIN (KXAN) — On Thursday, Gov. Greg Abbott sent a letter to Secretary of Agriculture Brooke Rollins asking for the United States Department of Agriculture (USDA) Food and Nutrition Service to ...